Acute Stroke Imaging Research Roadmap III Imaging Selection and Outcomes in Acute Stroke Reperfusion Clinical Trials Consensus Recommendations and Further Research Priorities
Standard
Acute Stroke Imaging Research Roadmap III Imaging Selection and Outcomes in Acute Stroke Reperfusion Clinical Trials Consensus Recommendations and Further Research Priorities. / Warach, Steven J; Luby, Marie; Albers, Gregory W; Bammer, Roland; Bivard, Andrew; Campbell, Bruce C V; Derdeyn, Colin; Heit, Jeremy J; Khatri, Pooja; Lansberg, Maarten G; Liebeskind, David S; Majoie, Charles B L M; Marks, Michael P; Menon, Bijoy K; Muir, Keith W; Parsons, Mark W; Vagal, Achala; Yoo, Albert J; Alexandrov, Andrei V; Baron, Jean-Claude; Fiorella, David J; Furlan, Anthony J; Puig, Josep; Schellinger, Peter D; Wintermark, Max; STIR/VISTA Imaging Collaboration.
in: STROKE, Jahrgang 47, Nr. 5, 05.2016, S. 1389-98.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Acute Stroke Imaging Research Roadmap III Imaging Selection and Outcomes in Acute Stroke Reperfusion Clinical Trials Consensus Recommendations and Further Research Priorities
AU - Warach, Steven J
AU - Luby, Marie
AU - Albers, Gregory W
AU - Bammer, Roland
AU - Bivard, Andrew
AU - Campbell, Bruce C V
AU - Derdeyn, Colin
AU - Heit, Jeremy J
AU - Khatri, Pooja
AU - Lansberg, Maarten G
AU - Liebeskind, David S
AU - Majoie, Charles B L M
AU - Marks, Michael P
AU - Menon, Bijoy K
AU - Muir, Keith W
AU - Parsons, Mark W
AU - Vagal, Achala
AU - Yoo, Albert J
AU - Alexandrov, Andrei V
AU - Baron, Jean-Claude
AU - Fiorella, David J
AU - Furlan, Anthony J
AU - Puig, Josep
AU - Schellinger, Peter D
AU - Wintermark, Max
AU - STIR/VISTA Imaging Collaboration
AU - Thomalla, Götz
N1 - © 2016 American Heart Association, Inc.
PY - 2016/5
Y1 - 2016/5
N2 - BACKGROUND AND PURPOSE: The Stroke Imaging Research (STIR) group, the Imaging Working Group of StrokeNet, the American Society of Neuroradiology, and the Foundation of the American Society of Neuroradiology sponsored an imaging session and workshop during the Stroke Treatment Academy Industry Roundtable (STAIR) IX on October 5 to 6, 2015 in Washington, DC. The purpose of this roadmap was to focus on the role of imaging in future research and clinical trials.METHODS: This forum brought together stroke neurologists, neuroradiologists, neuroimaging research scientists, members of the National Institute of Neurological Disorders and Stroke (NINDS), industry representatives, and members of the US Food and Drug Administration to discuss STIR priorities in the light of an unprecedented series of positive acute stroke endovascular therapy clinical trials.RESULTS: The imaging session summarized and compared the imaging components of the recent positive endovascular trials and proposed opportunities for pooled analyses. The imaging workshop developed consensus recommendations for optimal imaging methods for the acquisition and analysis of core, mismatch, and collaterals across multiple modalities, and also a standardized approach for measuring the final infarct volume in prospective clinical trials.CONCLUSIONS: Recent positive acute stroke endovascular clinical trials have demonstrated the added value of neurovascular imaging. The optimal imaging profile for endovascular treatment includes large vessel occlusion, smaller core, good collaterals, and large penumbra. However, equivalent definitions for the imaging profile parameters across modalities are needed, and a standardization effort is warranted, potentially leveraging the pooled data resulting from the recent positive endovascular trials.
AB - BACKGROUND AND PURPOSE: The Stroke Imaging Research (STIR) group, the Imaging Working Group of StrokeNet, the American Society of Neuroradiology, and the Foundation of the American Society of Neuroradiology sponsored an imaging session and workshop during the Stroke Treatment Academy Industry Roundtable (STAIR) IX on October 5 to 6, 2015 in Washington, DC. The purpose of this roadmap was to focus on the role of imaging in future research and clinical trials.METHODS: This forum brought together stroke neurologists, neuroradiologists, neuroimaging research scientists, members of the National Institute of Neurological Disorders and Stroke (NINDS), industry representatives, and members of the US Food and Drug Administration to discuss STIR priorities in the light of an unprecedented series of positive acute stroke endovascular therapy clinical trials.RESULTS: The imaging session summarized and compared the imaging components of the recent positive endovascular trials and proposed opportunities for pooled analyses. The imaging workshop developed consensus recommendations for optimal imaging methods for the acquisition and analysis of core, mismatch, and collaterals across multiple modalities, and also a standardized approach for measuring the final infarct volume in prospective clinical trials.CONCLUSIONS: Recent positive acute stroke endovascular clinical trials have demonstrated the added value of neurovascular imaging. The optimal imaging profile for endovascular treatment includes large vessel occlusion, smaller core, good collaterals, and large penumbra. However, equivalent definitions for the imaging profile parameters across modalities are needed, and a standardization effort is warranted, potentially leveraging the pooled data resulting from the recent positive endovascular trials.
KW - Journal Article
U2 - 10.1161/STROKEAHA.115.012364
DO - 10.1161/STROKEAHA.115.012364
M3 - SCORING: Journal article
C2 - 27073243
VL - 47
SP - 1389
EP - 1398
JO - STROKE
JF - STROKE
SN - 0039-2499
IS - 5
ER -
